DK1544199T3 - Nitrogenholdig kondenseret ringforbindelse og anvendelse deraf som HIV-integraseinhibitor - Google Patents

Nitrogenholdig kondenseret ringforbindelse og anvendelse deraf som HIV-integraseinhibitor

Info

Publication number
DK1544199T3
DK1544199T3 DK04771830T DK04771830T DK1544199T3 DK 1544199 T3 DK1544199 T3 DK 1544199T3 DK 04771830 T DK04771830 T DK 04771830T DK 04771830 T DK04771830 T DK 04771830T DK 1544199 T3 DK1544199 T3 DK 1544199T3
Authority
DK
Denmark
Prior art keywords
nitrogen
condensed ring
ring compound
hiv integrase
integrase inhibitor
Prior art date
Application number
DK04771830T
Other languages
Danish (da)
English (en)
Inventor
Susumu Miyazaki
Susumu Katoh
Kaoru Adachi
Hirotaka Isoshima
Satoru Kobayashi
Yuji Matsuzaki
Wataru Watanabe
Kazunobu Yamataka
Shinichi Kiyonari
Shuichi Wamaki
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34197143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1544199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Application granted granted Critical
Publication of DK1544199T3 publication Critical patent/DK1544199T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04771830T 2003-08-13 2004-08-12 Nitrogenholdig kondenseret ringforbindelse og anvendelse deraf som HIV-integraseinhibitor DK1544199T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003293117 2003-08-13
JP2004134896 2004-04-28
PCT/JP2004/011869 WO2005016927A1 (fr) 2003-08-13 2004-08-12 Compose azote a noyau condense et son utilisation en tant qu'inhibiteur d'integrase du vih

Publications (1)

Publication Number Publication Date
DK1544199T3 true DK1544199T3 (da) 2009-01-12

Family

ID=34197143

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04771830T DK1544199T3 (da) 2003-08-13 2004-08-12 Nitrogenholdig kondenseret ringforbindelse og anvendelse deraf som HIV-integraseinhibitor

Country Status (15)

Country Link
US (3) US20050054645A1 (fr)
EP (2) EP1544199B1 (fr)
JP (1) JP3814631B2 (fr)
AR (1) AR045367A1 (fr)
AT (1) ATE411315T1 (fr)
CA (1) CA2577239A1 (fr)
CL (1) CL2004002061A1 (fr)
DE (1) DE602004017108D1 (fr)
DK (1) DK1544199T3 (fr)
ES (1) ES2315700T3 (fr)
PE (1) PE20050361A1 (fr)
PT (1) PT1544199E (fr)
SI (1) SI1544199T1 (fr)
TW (1) TW200510425A (fr)
WO (1) WO2005016927A1 (fr)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006232849A (ja) * 2003-08-13 2006-09-07 Japan Tobacco Inc 含窒素縮合環化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
US7517994B2 (en) * 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7598383B2 (en) * 2003-11-19 2009-10-06 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) * 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
EP1725554A1 (fr) * 2004-03-09 2006-11-29 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Inhibiteurs de l'int grase du vih
WO2005092099A1 (fr) * 2004-03-09 2005-10-06 Merck & Co., Inc. Inhibiteurs de l'integrase du vih
EP1725556A1 (fr) * 2004-03-09 2006-11-29 Merck & Co., Inc. Inhibiteurs de l'int grase du vih
US7619086B2 (en) * 2004-03-09 2009-11-17 Merck & Co., Inc. HIV integrase inhibitors
US7115601B2 (en) * 2004-05-18 2006-10-03 Bristol-Myers Squibb Company HIV integrase inhibitors
JP4629104B2 (ja) * 2004-05-21 2011-02-09 日本たばこ産業株式会社 ４−オキソキノリン誘導体および抗ｈｉｖ剤を含む併用剤
EP1790638B1 (fr) 2004-09-15 2013-04-03 Shionogi Co., Ltd. Dérivé de carbamoylpyridone ayant une activité d'inhibition de la vih intégrase
US7745459B2 (en) * 2004-09-21 2010-06-29 Japan Tobacco Inc. Quinolizinone compound and use thereof as HIV integrase inhibitor
US7858788B2 (en) * 2005-02-21 2010-12-28 Shionogi & Co., Ltd. Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
EP1866313A1 (fr) * 2005-03-31 2007-12-19 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Inhibiteurs de l`integrase du vih
EP2465580B1 (fr) 2005-04-28 2013-12-18 VIIV Healthcare Company Dérivés de carbamoylpyridone polycyclique dotés d'une activité inhibitrice de l'intégrase du VIH
EP1879607B1 (fr) 2005-05-02 2014-11-12 Merck Sharp & Dohme Corp. Inhibiteurs de la protease ns3 du vhc
JP4982482B2 (ja) * 2005-05-10 2012-07-25 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラ−ゼ阻害剤
CN102942522A (zh) * 2005-05-18 2013-02-27 阵列生物制药公司 Mek的杂环抑制剂及其使用方法
JP2006342115A (ja) * 2005-06-10 2006-12-21 Shionogi & Co Ltd Ｈｉｖインテグラーゼ阻害活性を有する多環性化合物
CA2616314A1 (fr) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Composes antiviraux
RU2008107972A (ru) 2005-08-01 2009-09-10 Мерк энд Ко., Инк. (US) Макроциклические пептиды в качестве ингибиторов ns3-протеазы hcv
US7939537B2 (en) * 2005-10-04 2011-05-10 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HIV integrase inhibitors
BRPI0617842A2 (pt) * 2005-10-27 2011-08-09 Shionogi & Co composto ou um sal farmaceuticamente aceitável ou um solvato do mesmo, e, composição farmacêutica
EP2452682A1 (fr) * 2006-02-01 2012-05-16 Japan Tobacco, Inc. Utilsation d'acide 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylique ou d'un ses sels pour traiter use infection rétrovirale
GB0609492D0 (en) 2006-05-15 2006-06-21 Angeletti P Ist Richerche Bio Therapeutic agents
EP2066670A2 (fr) * 2006-05-16 2009-06-10 Gilead Sciences, Inc. Inhibiteurs d'intégrase
GB0612423D0 (en) 2006-06-23 2006-08-02 Angeletti P Ist Richerche Bio Therapeutic agents
EP2084160A1 (fr) * 2006-10-18 2009-08-05 Merck & Co., Inc. Inhibiteurs du vih intégrase
US8377873B2 (en) 2006-10-24 2013-02-19 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
CA2667266C (fr) 2006-10-24 2015-11-24 Merck & Co., Inc. Inhibiteurs de la protease ns3 du hcv
AU2007309544B2 (en) 2006-10-24 2012-05-31 Msd Italia S.R.L. HCV NS3 protease inhibitors
CA2667032A1 (fr) 2006-10-27 2008-05-15 Merck & Co., Inc. Inhibiteurs de protease ns3 du vhc
BRPI0718161A2 (pt) 2006-10-27 2013-11-26 Merck & Co Inc Composto, composição farmacêutica, e, uso do composto.
GB0625349D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
US8101595B2 (en) 2006-12-20 2012-01-24 Istituto di Ricerche di Biologia Molecolare P. Angletti SpA Antiviral indoles
GB0625345D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2008085508A2 (fr) 2007-01-05 2008-07-17 Merck & Co., Inc. Phosphoramidates d'aryle nucléosidiques destinés au traitement de l'infection virale d'arn arn dépendante
AU2008277440A1 (en) 2007-07-17 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Macrocyclic indole derivatives for the treatment of hepatitis C infections
CA2699891C (fr) 2007-07-19 2013-10-22 Nigel Liverton Composes macrocycliques servant d'agents antiviraux
WO2009067541A2 (fr) * 2007-11-20 2009-05-28 Gilead Sciences, Inc. Inhibiteurs d'intégrase
EP3085377A1 (fr) 2008-01-25 2016-10-26 Chimerix, Inc. Méthodes de traitement d'infections virales
CN102014911A (zh) 2008-04-28 2011-04-13 默沙东公司 Hcv ns3蛋白酶抑制剂
WO2010006438A1 (fr) 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Composés inhibiteurs et procédés de traitement du cancer
RS52534B (en) 2008-07-22 2013-04-30 Merck Sharp & Dohme Corp. MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS
WO2010011818A1 (fr) * 2008-07-25 2010-01-28 Smithkline Beecham Corporation Composés chimiques
WO2010011819A1 (fr) * 2008-07-25 2010-01-28 Smithkline Beecham Corporation Composés chimiques
JP5586602B2 (ja) 2008-07-25 2014-09-10 ビーブ・ヘルスケア・カンパニー 化合物
WO2010042392A2 (fr) * 2008-10-06 2010-04-15 Merck & Co., Inc. Inhibiteurs de l'intégrase du vih
KR101682058B1 (ko) * 2008-12-11 2016-12-02 비이브 헬쓰케어 컴퍼니 카르바모일피리돈 ｈｉｖ 인테그라제 억제제를 위한 제조방법 및 중간체
AU2009325128B2 (en) * 2008-12-11 2015-01-29 Shionogi & Co., Ltd. Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
WO2010082050A1 (fr) 2009-01-16 2010-07-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Composés benzoxazocines substitués 7-aminoalkyle macrocycycliques destinés au traitement des infections par hépatite c
GB0900914D0 (en) 2009-01-20 2009-03-04 Angeletti P Ist Richerche Bio Antiviral agents
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
US8927710B2 (en) * 2009-06-15 2015-01-06 Shionogi & Co., Ltd. Substituted polycyclic carbamoylpyridone derivative
WO2011014487A1 (fr) 2009-07-30 2011-02-03 Merck Sharp & Dohme Corp. Inhibiteurs de protéase ns3 du virus de l'hépatite c
ES2969969T3 (es) 2010-01-27 2024-05-23 Viiv Healthcare Co Combinaciones de dolutegravir y lamivudina para el tratamiento de la infección por VIH
PT2534150T (pt) 2010-02-12 2017-05-02 Chimerix Inc Métodos para tratar uma infecção viral
WO2011105590A1 (fr) * 2010-02-26 2011-09-01 日本たばこ産業株式会社 Dérivé de 1,3,4,8-tétrahydro-2h-pyrido[1,2-a]pyrazine et son utilisation comme inhibiteur d'intégrase de vih
TWI582097B (zh) 2010-03-23 2017-05-11 Ｖｉｉｖ醫療保健公司 製備胺甲醯吡啶酮衍生物及中間體之方法
US8987272B2 (en) 2010-04-01 2015-03-24 Critical Outcome Technologies Inc. Compounds and method for treatment of HIV
WO2011129095A1 (fr) * 2010-04-12 2011-10-20 塩野義製薬株式会社 Dérivé de pyridone ayant une activité inhibitrice de l'intégrase
KR101851518B1 (ko) 2010-09-08 2018-04-23 스미또모 가가꾸 가부시끼가이샤 피리다지논 화합물 및 그 중간체의 제조 방법
PL2620436T3 (pl) 2010-09-24 2018-10-31 Shionogi & Co., Ltd. Prolek podstawionej policyklicznej pochodnej karbamoilopirydonowej
BR112014008896A2 (pt) 2011-10-12 2017-04-18 Shionogi & Co derivado de piridona policíclico tendo atividade inibidora de integrase
EP2780026B1 (fr) 2011-11-15 2019-10-23 Merck Sharp & Dohme Corp. Inhibiteurs de la protéase ns3 du vhc
WO2014099586A1 (fr) * 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. Dérivés 4-pyridinonetriazines en tant qu'inhibiteurs de l'intégrase du vih
UY35213A (es) 2012-12-21 2014-06-30 Gilead Sciences Inc Compuestos del tipo de las carbamilpiridonas policíclicas y su uso farmaceutico
US20140221378A1 (en) * 2012-12-27 2014-08-07 Japan Tobacco Inc. SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR
WO2014121417A1 (fr) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c
WO2014121416A1 (fr) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c
WO2014121418A1 (fr) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Composés hétérocycliques tétracycliques et leurs méthodes d'utilisation pour le traitement de l'hépatite c
EP2986291B1 (fr) 2013-04-16 2020-05-27 Merck Sharp & Dohme Corp. Composés dérivés de 4-pyridone et leurs utilisations en tant qu'inhibiteurs de la vih intégrase
HUE036384T2 (hu) 2013-05-17 2018-07-30 Merck Sharp & Dohme Fúzionált triciklusos heterociklikus vegyületek mint HIV integráz inhibitorok
WO2014200880A1 (fr) 2013-06-13 2014-12-18 Merck Sharp & Dohme Corp. Composés hétérocycliques tricycliques fusionnés utiles en tant qu'inhibiteurs de l'intégrase du vih
WO2015001572A2 (fr) * 2013-07-04 2015-01-08 Hetero Research Foundation Procédé pour la préparation d'intermédiaire de dolutégravir
AU2014286993B2 (en) 2013-07-12 2018-10-25 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their use for the treatment of HIV infections
NO2865735T3 (fr) 2013-07-12 2018-07-21
US9328119B2 (en) * 2013-09-12 2016-05-03 Alios Biopharma, Inc. AZA-pyridone compounds and uses thereof
US9861620B2 (en) 2013-09-27 2018-01-09 Merck Sharp & Dohme Corp. Substituted quinolizine derivatives useful as HIV integrase inhibitors
WO2015089847A1 (fr) * 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Composés à hétérocycles spirocycliques utiles en tant qu'inhibiteurs d'intégrase du vih
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
NO2717902T3 (fr) 2014-06-20 2018-06-23
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
EP3164136A4 (fr) 2014-07-02 2018-04-04 Ligand Pharmaceuticals, Inc. Composés de promédicaments et leurs utilisations
EP3166951A1 (fr) * 2014-07-07 2017-05-17 Savira Pharmaceuticals GmbH Dihydropyridopyrazine-1,8-diones et leur utilisation dans le traitement, le soulagement ou la prévention de maladies virales
CN107001355A (zh) * 2014-07-07 2017-08-01 萨维拉制药有限公司 吡啶并吡嗪化合物和它们在治疗、改善或预防流感中的用途
EP3757105B1 (fr) 2014-08-22 2024-07-24 Shionogi & Co., Ltd. Dérivé de pyridone polycyclique possédant une activité inhibitrice d'intégrase
WO2016090545A1 (fr) * 2014-12-09 2016-06-16 Merck Sharp & Dohme Corp. Composés hétérocycliques spirocycliques utiles en tant qu'inhibiteurs de l'intégrase du vih
TWI738321B (zh) 2014-12-23 2021-09-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
WO2016145103A1 (fr) 2015-03-11 2016-09-15 Alios Biopharma, Inc. Composés d'aza-pyridone et leurs utilisations
NZ735575A (en) 2015-04-02 2018-11-30 Gilead Sciences Inc Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
LT4219508T (lt) 2015-04-28 2024-08-26 Shionogi & Co., Ltd Pakeistas policiklinis piridono darinys ir jo provaistas
CN113004304B (zh) 2015-04-28 2022-03-18 盐野义制药株式会社 经取代的多环性吡啶酮衍生物及其前药
WO2016187788A1 (fr) 2015-05-25 2016-12-01 Merck Sharp & Dohme Corp. Composés hétérocycliques tricycliques fusionnés utiles pour traiter l'infection au vih
EP3377066B1 (fr) 2015-11-17 2021-04-07 Merck Sharp & Dohme Corp. Dérivés de pyridotriazine amido-substitués utiles en tant qu'inhibiteurs de l'intégrase du vih
WO2017106071A1 (fr) 2015-12-15 2017-06-22 Merck Sharp & Dohme Corp. Dérivés de quinolizine spirocycliques utiles en tant qu'inhibiteurs de l'intégrase du vih
SG11201804348SA (en) 2015-12-15 2018-06-28 Shionogi & Co Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug
WO2017113288A1 (fr) 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Composés hétérocycliques tricycliques condensés utiles en tant qu'inhibiteurs de l'intégrase du vih
JP6918819B2 (ja) 2016-03-08 2021-08-11 ノバルティス アーゲー オルトミクソウイルス感染の処置に有用な三環式化合物
BR112019001911A2 (pt) 2016-08-10 2019-05-07 Shionogi & Co., Ltd. derivado de piridona policíclica substituída e pró-fármaco contendo composição farmacêutica do mesmo
JOP20170169A1 (ar) 2016-08-29 2019-01-30 Novartis Ag مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو
EP3548031B1 (fr) 2016-12-02 2023-07-19 Merck Sharp & Dohme LLC Composés hétérocycliques tricycliques utiles en tant qu'inhibiteurs de l'intégrase du vih
JOP20190130A1 (ar) 2016-12-02 2019-06-02 Merck Sharp & Dohme مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
US10786488B2 (en) 2017-01-26 2020-09-29 Merck Sharp & Dohme Corp. Substituted quinolizine derivatives useful as HIV integrase inhibitors
AU2019207625A1 (en) 2018-01-09 2020-07-30 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
JP7065989B2 (ja) 2018-02-28 2022-05-12 ノバルティス アーゲー インフルエンザを処置するためのオルソミクソウイルス複製の阻害剤としての１０－（ジ（フェニル）メチル）－４－ヒドロキシ－８，９，９ａ，１０－テトラヒドロ－７Ｈ－ピロロ［１’，２’：４，５］ピラジノ［１，２－ｂ］ピリダジン－３，５－ジオン誘導体および関連化合物
EP3784241A4 (fr) * 2018-04-27 2022-01-19 Merck Sharp & Dohme Corp. Composés hétérocycliques tricycliques utiles en tant qu'inhibiteurs de l'intégrase du vih
IL279051B1 (en) 2018-05-31 2024-09-01 Shionogi & Co Consequences of polycyclic carbamoylpyridone
AU2019277547A1 (en) 2018-05-31 2021-01-14 Shionogi & Co., Ltd. Polycyclic pyridone derivative
EP3815689A4 (fr) * 2018-06-27 2022-04-20 National University Corporation Hokkaido University Inhibiteur de la croissance d'arénavirus comprenant un dérivé de carbamoylpyridone polycyclique
WO2020053654A1 (fr) 2018-09-12 2020-03-19 Novartis Ag Composés antiviraux de pyridopyrazinedione
US20200398978A1 (en) 2019-06-20 2020-12-24 Bell Helicopter Textron Inc. Low-drag rotor blade extension
KR20220070005A (ko) 2019-09-26 2022-05-27 노파르티스 아게 항바이러스성 피라졸로피리디논 화합물
JPWO2021107066A1 (fr) 2019-11-28 2021-06-03
CN116724038A (zh) 2020-10-21 2023-09-08 安力高医药股份有限公司 双环化合物
WO2022266193A1 (fr) 2021-06-18 2022-12-22 Aligos Therapeutics, Inc. Composés bicycliques
WO2024151855A1 (fr) * 2023-01-13 2024-07-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibiteurs de transfert de brins intégrase à base de carbamoyl pyridone bicyclique

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2502281B2 (ja) 1985-02-25 1996-05-29 キヤノン株式会社 情報信号処理装置
CA1317298C (fr) 1987-03-03 1993-05-04 Upjohn Company (The) .beta.-lactames antibiotiques activees par des groupes sulfonylaminocar bonyles
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
JP2993316B2 (ja) * 1992-05-27 1999-12-20 宇部興産株式会社 アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
TW477787B (en) * 1996-08-27 2002-03-01 Pfizer Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
US6770666B2 (en) * 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
WO2001095905A1 (fr) 2000-06-14 2001-12-20 Shionogi & Co., Ltd. Inhibiteur d'enzymes possedant deux ions metal divalents en tant que centres actifs
CA2412985A1 (fr) 2000-06-16 2001-12-27 Bristol-Myers Squibb Company Inhibiteurs d'integrase du vih
AU2001286188A1 (en) 2000-09-11 2002-03-26 Takeda Chemical Industries Ltd. Tricyclic heterocyclic compound, process for producing the same, and use thereof
JP2002155084A (ja) * 2000-09-11 2002-05-28 Takeda Chem Ind Ltd ３環性複素環化合物、その製造法およびその用途
US6841558B2 (en) 2000-10-12 2005-01-11 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors
JP2004513134A (ja) 2000-10-12 2004-04-30 メルク　エンド　カムパニー　インコーポレーテッド Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルケトン類
WO2002030426A1 (fr) 2000-10-12 2002-04-18 Merck & Co., Inc. Azanaphthalenylcarboxamides et polyazanaphthalenylcarboxamides utiles en tant qu'inhibiteurs de la vih integrase
EA200300449A1 (ru) 2000-10-12 2003-10-30 Мерк Энд Ко., Инк. Аза- и полиаза-нафталинилкарбоксамиды, полезные в качестве ингибиторов вич-интегразы
JP2002293745A (ja) 2001-03-29 2002-10-09 St Marianna Univ School Of Medicine 慢性関節リウマチ治療剤
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
ATE550320T1 (de) 2001-08-10 2012-04-15 Shionogi & Co Antivirales mittel
WO2003016266A1 (fr) 2001-08-16 2003-02-27 Japan Tobacco Inc. Composes $g(b)-cetoamides et leur utilisation medicinale
FR2830863B1 (fr) 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
RS51542B (sr) 2001-10-26 2011-06-30 Istituto Di Ricerche Di Biologia Molecolare P.Angeletti Spa. N-supstituisani hidroksipirimidinon karboksamidni inhibitori hiv integraze
PT1441734E (pt) 2001-10-26 2007-05-31 Isti Di Ric Di Bio Moleco P An Di-hidroxipirimidinocarboxamidas inibidoras da integrase do vih
AU2002349675A1 (en) 2001-12-05 2003-06-17 Shionogi And Co., Ltd. Derivative having hiv integrase inhibitory activity
US7279487B2 (en) * 2002-01-17 2007-10-09 Merck & Co., Inc. Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
EP1549315A4 (fr) 2002-09-11 2007-05-23 Merck & Co Inc Composes de dihydroxypyridopyrazine-1,6-diones utiles en tant qu'inhibiteurs de l'integrase du vih
CL2004002050A1 (es) * 2003-08-13 2005-06-03 Pharmacia Corp Sa Organizada B Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
US7247649B2 (en) * 2003-08-13 2007-07-24 Hoffmann-La Roche Inc. Oxazoles, their manufacture and use as pharmaceutical agents
NZ545159A (en) * 2003-08-13 2009-03-31 Smith Howard J & Ass Pty Ltd Method of treating viral infections
EP1725556A1 (fr) 2004-03-09 2006-11-29 Merck & Co., Inc. Inhibiteurs de l'int grase du vih
EP1725554A1 (fr) 2004-03-09 2006-11-29 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Inhibiteurs de l'int grase du vih
US7619086B2 (en) 2004-03-09 2009-11-17 Merck & Co., Inc. HIV integrase inhibitors
WO2005092099A1 (fr) 2004-03-09 2005-10-06 Merck & Co., Inc. Inhibiteurs de l'integrase du vih
GB0417494D0 (en) * 2004-08-05 2004-09-08 Glaxosmithkline Biolog Sa Vaccine
WO2006066414A1 (fr) 2004-12-23 2006-06-29 Virochem Pharma Inc. Hydroxydihydropyridopy razine-1,8-diones et procedes d’inhibition de l’integrase du vih
US7858788B2 (en) * 2005-02-21 2010-12-28 Shionogi & Co., Ltd. Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity

Also Published As

Publication number Publication date
TW200510425A (en) 2005-03-16
DE602004017108D1 (de) 2008-11-27
JPWO2005016927A1 (ja) 2006-10-12
US20050054645A1 (en) 2005-03-10
EP1544199B1 (fr) 2008-10-15
US20060052361A1 (en) 2006-03-09
EP1544199A1 (fr) 2005-06-22
WO2005016927A1 (fr) 2005-02-24
AR045367A1 (es) 2005-10-26
US7211572B2 (en) 2007-05-01
PT1544199E (pt) 2008-12-03
JP3814631B2 (ja) 2006-08-30
SI1544199T1 (sl) 2009-04-30
CL2004002061A1 (es) 2005-06-03
CA2577239A1 (fr) 2005-02-24
EP1544199A4 (fr) 2006-07-26
ES2315700T3 (es) 2009-04-01
ATE411315T1 (de) 2008-10-15
EP2042502A1 (fr) 2009-04-01
PE20050361A1 (es) 2005-06-27
US20080161311A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
DK1544199T3 (da) Nitrogenholdig kondenseret ringforbindelse og anvendelse deraf som HIV-integraseinhibitor
NO20043004L (no) 4-oksokinolin forbindelse og anvendelse derav som HIV-integraseinhibitor
AU2003248872A8 (en) Hiv integrase inhibitors
NO20064555L (no) HIV-integraseinhibitorer.
NO20031672D0 (no) Aza- og polyaza-naftalenylkarboksamider for anvendelse som HIV-integraseinhibitorer
NO20052378D0 (no) Pre-organiserte trisykliske integraseinhibitorforbindelser
EP1725535A4 (fr) Inhibiteurs de l'integrase du vih
EP1756069A4 (fr) Inhibiteurs d'integrase de vih
IL177189A0 (en) Hiv integrase inhibitors
EP1725102A4 (fr) Inhibiteurs de l'integrase du vih
DE602005009172D1 (de) Hiv-integrase-inhibitoren: cyclische pyrimidinonverbindung
ATE461202T1 (de) Hiv-integrasehemmer
EP1549315A4 (fr) Composes de dihydroxypyridopyrazine-1,6-diones utiles en tant qu'inhibiteurs de l'integrase du vih
IS7427A (is) 3-sýklýl-5-(5-hluta hringur sem inniheldur köfnunarefni) metýl-oxasólídínónafleiður og notkun þeirra sem bakteríueyðandi efna
DK1326864T3 (da) Sammenföjede aryl- eller heteroarylforbindelser som antiinflammatoriske og analgetiske midler
DE60320933D1 (de) Rho-kinase inhibitoren
NO20050665L (no) Pyrrolidonderivater som MAOE inhibitoere
IS7138A (is) Alkýn-arýl fosfódíesterasa-4 hindrar
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
EP1756114A4 (fr) Inhibiteurs de l'integrase du vih
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
ZA200306549B (en) Benzophenones as inhibitors of reverse transcriptase.
IS7305A (is) HIV-integrasa tálmar
NO20040996L (no) Nye forbindelser og sammensetninger som catepsin-inhibitorer
IS7585A (is) Ný piperadín efnasambönd